Anixa Biosciences Inc
ANIX
Get informed when a big investor buys or sells
+ FollowMarket Cap$99.01M
Close$
$0.03
98.8% downside
Current Fair Value
98.8% downsideOvervalued by 98.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $99.01 Million |
|---|---|
| Enterprise Value | $97.71 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.34 |
| Beta | 0.6 |
| Outstanding Shares | 33,593,000 |
Return
| Return on Equity | -54.00% |
|---|---|
| Return on Assets | -52.58% |
| Return on Invested Capital | -79.06% |
Valuation & Multiples
| P/E Ratio | -9.76 |
|---|---|
| PEG | 116.31 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -9.25 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 10, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 10, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 70,900▲ 250.99% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 15.36%▼ 2.06% |
|---|---|
| Total Invested | $13.18M▼ 25.29% |
| Investors Holding | 63▼ 8.00% |
ESG Score
No data
About Anixa Biosciences Inc
CEO: Amit Kumar